← Leaderboards
Chongzhao Ran
Massachusetts General Hospital
$9,592,256
Attributed
$10,408,424
Total exposure
13
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,408,424 · 13
By mechanism
R01$5,418,461 · 3
R21$2,310,450 · 5
R56$1,138,965 · 2
K25$769,575 · 1
S10$599,933 · 1
R03$171,040 · 1
Top collaborators
- Can Martin Zhang2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jacob M. Hooker$9,881,958
- Stephen N. Gomperts$8,663,513
- Marc David Normandin$9,929,917
- John W Chen$9,274,164
- Alexei A Bogdanov$13,760,247
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBrainMonitorS DiseaseImagePositron-Emission TomographyDrug DevelopmentImaging ModalityIn VitroIn VivoAmyloid Beta-ProteinDesignImaging ProbeAntibodiesPre-ClinicalFluorescenceFutureCurcuminApp-Ps1Clinical TrialsPharmaceutical PreparationsNear-Infrared Optical ImagingValidationPenetration
Grant awards (28)
Development of sensitive PET tracers of pan-Amyloid-beta species for Alzheimer's disease$810,197
R01 · FY2025 · AG · contact PI
Molecular Chemiluminescence Probes for Imaging of Amyloid beta in Animal Models$808,786
R01 · FY2025 · AG · contact PI
Development of sensitive PET tracers of pan-Amyloid-beta species for Alzheimer's disease$826,732
R01 · FY2024 · AG · contact PI
Molecular Chemiluminescence Probes for Imaging of Amyloid beta in Animal Models$823,551
R01 · FY2024 · AG · contact PI
Epitope alteration for detecting auto-antibodies of beta-amyloid in serum$458,585
R21 · FY2023 · AG · contact PI
Differentiating Abeta40/42 in plaques with small molecule fluorescent probes$459,280
R21 · FY2022 · AG · contact PI
Near infrared fluorescence imaging of reactive oxygen species in Alzheimer's disease$419,880
R01 · FY2022 · AG · contact PI
Near infrared fluorescence imaging of reactive oxygen species in Alzheimer's disease$419,880
R01 · FY2021 · AG · contact PI
Upgrade and replacement of IVIS Spectrum imaging system$599,933
S10 · FY2020 · OD · contact PI
Imaging active plaques of Alzheimers disease$458,594
R21 · FY2020 · AG · contact PI
Near infrared fluorescence imaging of reactive oxygen species in Alzheimer's disease$419,880
R01 · FY2020 · AG · contact PI
Fluorescence ocular imaging for preliminarily screening of Alzheimer's$571,820
R56 · FY2019 · AG · contact PI
Near infrared fluorescence imaging of reactive oxygen species in Alzheimer's disease$419,880
R01 · FY2019 · AG · contact PI
Near infrared Fluorescence Ocular Imaging of Soluble Amyloid Beta Species$208,536
R21 · FY2019 · AG · contact PI
Near infrared fluorescence imaging of reactive oxygen species in Alzheimer's disease$49,795
R01 · FY2019 · AG · contact PI
Near infrared fluorescence imaging of reactive oxygen species in Alzheimer's disease$419,880
R01 · FY2018 · AG · contact PI
Near infrared Fluorescence Ocular Imaging of Soluble Amyloid Beta Species$250,661
R21 · FY2018 · AG · contact PI
Imaging brown adipose tissue and monitoring browning$277,770
R56 · FY2017 · DK · contact PI
Imaging brown adipose tissue and monitoring browning$289,375
R56 · FY2016 · DK · contact PI
Double-blocking Anti-crosslinking Strategy for AD Drug Development$215,647
R21 · FY2016 · AG · contact PI
Near-infrared molecular imaging for monitoring therapy in AD mouse models$85,520
R03 · FY2016 · AG · contact PI
Double-blocking Anti-crosslinking Strategy for AD Drug Development$259,147
R21 · FY2015 · AG · contact PI
Near-infrared molecular imaging for monitoring therapy in AD mouse models$85,520
R03 · FY2015 · AG · contact PI
Imaging AD Amyloidosis Pathology by Novel Multi-modal NIR/PET/19F MRI Probes$153,996
K25 · FY2014 · AG · contact PI
Imaging AD Amyloidosis Pathology by Novel Multi-modal NIR/PET/19F MRI Probes$153,996
K25 · FY2013 · AG · contact PI
Imaging AD Amyloidosis Pathology by Novel Multi-modal NIR/PET/19F MRI Probes$153,996
K25 · FY2012 · AG · contact PI
Imaging AD Amyloidosis Pathology by Novel Multi-modal NIR/PET/19F MRI Probes$153,996
K25 · FY2011 · AG · contact PI
Imaging AD Amyloidosis Pathology by Novel Multi-modal NIR/PET/19F MRI Probes$153,591
K25 · FY2010 · AG · contact PI